Adamas Pharmaceuticals
ADMS
#7086
Rank
HK$2.92 B
Marketcap
HK$63.96
Share price
0.00%
Change (1 day)
16,285.99%
Change (1 year)

Revenue for Adamas Pharmaceuticals (ADMS)

Revenue in 2021 (TTM): HK$0.68 Billion

According to Adamas Pharmaceuticals 's latest financial reports the company's current revenue is HK$0.68 Billion. In 2020 the company made a revenue of HK$0.57 Billion an increase over the revenue in the year 2019 that were of HK$0.42 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Adamas Pharmaceuticals from 2013 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)HK$0.68 B18.26%
2020HK$0.57 B36.28%
2019HK$0.42 B60.48%
2018HK$0.26 B
2016HK$4.45 M-70.15%
2015HK$14.9 M-96.57%
2014HK$0.43 B-21.45%
2013HK$0.55 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$0.63 B-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.90 B 614.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$427.97 B 62,266.05%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$313.22 B 45,543.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$486.17 B 70,746.70%๐Ÿ‡บ๐Ÿ‡ธ USA